Avantor collaborates with Mission-Critical Solutions at CPHI & PMEC India 2025
Avantor, a global life science tools company and leading provider of mission-critical products and services to the life sciences…
Author
Glenmark Pharmaceuticals receives EIR from US FDA for its Monroe facility
Glenmark Pharmaceuticals, a research-led, global pharmaceutical company announced that it has received the Establishment…
The development of medico-legal governance in pharma companies
While the field of global healthcare is transforming at a breakneck pace, the pharmaceutical industry finds itself at a critical…
Eisai completes rolling submission to US FDA for LEQEMBI IQLIK supplemental biologics license…
Eisai announced that it has completed the rolling submission of the Supplemental Biologics License Application (sBLA) to the US…
Panel Discussion: Moving up the value chain without losing volume advantage
Bengaluru Pharma Summit 2025 | 12th September 2025 | Bengaluru
Dr Huzaifa Shabbir Choonia, Director and Head, Drug Substance-MSAT, OneSource
Bengaluru Pharma Summit 2025 | 12th September 2025 | Bengaluru
Mr Markus Obkircher, Director, Head of Customer Solutions R&D, Chemistry, Merck KGaA
Bengaluru Pharma Summit 2025 | 12th September 2025 | Bengaluru
Dr Rakesh Bhasin, Head R&D (Formulations), Biocon
Bengaluru Pharma Summit 2025 | 12th September 2025 | Bengaluru
Panel Discussion: Bengaluru: An emerging global innovation gateway
Bengaluru Pharma Summit 2025 | 12th September 2025 | Bengaluru
Mr Loganathan S, Associate VP, Onesource Biopharma
Bengaluru Pharma Summit 2025 | 12th September 2025 | Bengaluru